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Hopenhayn-Rich*
Toluene isawidely usedindustrial solvent, andhumansmay alsohavehighexposures totoluenefromthedeliberate
inhalation("9miffn")ofpaintreducer, paintthiner, orpaintfortheirnarcticeffects. Anumberofcasereportsdescribe
neonataleffectsthathavebeenattributedto ohieneabuseduringp . Theseeffectsmay includeintratrn grwth
retardation, premature delivery, congenital malformations, and postnataldevelopmental retardation. Thepossibility of
exposures tootherfetotoxic agents, eitherasinpuritiesoradmixt intoluene-containing products, orby deliberate
oraccidentalexpouers tootherchemcalsordrugs,cannotbeexcludedinthesecases. Thefetotoxiceffectsoftoluenehave
beendemonstratedincontrolledstudies inanimalsandarecomparable tothoseobservedinhumanswhohaveabused
toluene-containing products before or during pregnancy. Intrauterine developmental retardation is the most clearly
establishedeffectinanimals, asevidencedbydecreasedlatefetalweightandreardedskeletaldevelopment. Thereisalso
limitedevidenceinrodentsforskeletalandkidneyabnormaltes, asweli assomeevidenceforeffectsonpostnatalphycl
andpossiblyneurobehavioraldevelopment. teddailyexpsr fromexperimentalstudiesinanimalsarecompared
to estimated human dailly intakes at the occupational permissible exposure level and at the level reported to produce
euphoria inhumans. AcceptablehumanintakesunderCalifornia'sProposition65andunderU.S. Environmental Pro-
tection Agency procedures arediscussed.
Introduction
A subject of current concern to many people is environmen-
tal and occupational exposures to agents that may cause repro-
ductive and developmental toxicity. This is evidenced in
California by the passage of Proposition 65 (the Safe Drink-
ing Water and Toxics Enforcement Act of 1986), which re-
quires regulation of agents known to the State to be reproduc-
tive/developmental toxicants (1). The evidence for reproduc-
tive/developmental toxicity oftoluene in animals and humans
is reviewed here. Exposures to high levels of toluene occur
through the practice of deliberate inhalation ("sniffing") for
the narcotic effects ofthe chemical (2,3). Sniffing oftoluene
by pregnant women has also resulted in prenatal toluene ex-
posure in human infants, and there are a number of case
reports of effects such as intrauterine growth retardation
among infants of mothers with such exposures (Table 1).
Therefore, reason for concern exists about the potential
reproductive/developmental toxicity of toluene.
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Production, Use, and Exposure
to Toluene
Toluene(toluol;methylbenzene;phenylmethane),anaromatic
hydrocarbonsimilartobenzene, isusedmainly(92%)asacom-
ponent ofgasoline, which contains 5 to 7% toluene by weight
(4,5). Production intheU.S. was6.9 x 109 lb in 1988 (6), and
0.1% ofthisamount(approximately7millionlb)wasreleasedin-
to the environment in California during the same year (7).
Toluene is used in the production of a number of industrial
chemicals (benzene, toluene diisocyanate, phenol, benzyl and
benzoyl derivatives, benzoic acid, toluene sulfonates, nitro-
toluenes, vinyl toluene, and saccharin) and is a byproduct of
styrene production and coke-oven operations (4,8). Toluene is
alsoused as a solvent forpaints, lacquers, and adhesives.
Inhalationofairbornetolueneisthemainsourceofhuman ex-
posures, whichmayoccurduringtheproduction, transport, and
useofgasolineortolueneorbydeliberateinhalation.Thegreatest
riskofaccidentalexposurestotoluenearelikelytooccuramong
paint workers, dye makers, and workers in the chemical and
petrochemicalindustry. Consumerexposuremayoccurthrough
the use of toluene-containing products such as gasoline,
cosmetics,rubbercement,nailpolish,stainremovers,paintbrush
cleaners, fabricdyes, inks, adhesives, andcigarettesmoke(4).
In addition, thepractice ofintentional inhalation exposure for
narcoticeffectsmayproduceprolongedexposurestogreaterthanDONALDETAL.
TIble 1. Studiesorreportsofreproductive and/ordevelopmental toxicity oftoluene inhumans.
Authors Typeofstudy Evaluated population Routeofexposure Adverseeffects
Epidemiological study
McDonald etal., 1987 (14) Case-referent study ofoccu- 301 infants with acongenital Occupational exposuresofthe Kidney/urinary, gastrointestinal
pationally exposed women deformity paired with 301 mothers tochemicals and cardiac anomalies
normal infants
Case reports
Hersh, 1989 (15) Case reports: developmental Offspring (3)ofthree women Sniffing ofpaintreducer(all Prematuredelivery, malforma-
exposedduringpregnancy cases) andpaint (2 cases) tions, retardedphysical and
cognitivedevelopment
Goodwin, 1988(16) Case reports: developmental Offspring (5) offive women Sniffingofpaint IUGR,' prematuredelivery,
exposed during pregnancy malformations, retarded
cognitiveand motor
development
Hersh et al., 1985 (17) Case reports: developmental Offspring (2) oftwo women Sniffing oftoluenepaint IUGR, malfomations, retarded
exposed during pregnancy reducer physical andcognitive
development
Suzuki et al., 1983 (3) Case report: adult male Single adult male Sniffing ofthinner(toluene) Testicularatrophy, suppressed
spermatogenesis
'IUGR, intrauterine growth retardation.
500ppm, thelevelatwhichnarcoticeffectshavebeenreported
(9). Thecurrentpermissibleexposurelimit(PEL)fortoluenein
airestablishedbytheU.S. Occupational SafetyandHealthAd-
ministration (OSHA) andbytheCalifornia DivisionofOccupa-
tional Safety and Health is 100 ppm (375 mg/m3). This value
referstoa-time-weightedaverageexposureoveran8-hrworkday.
Environmentalreleaseoftoluenemayresultfromautomobile
exhaust, theproductionanduseoftoluene-containingproducts,
orcontaminationfromdisposaloftolueneortoluene-containing
productsathazardouswastesites. Duringa 1988 EPAsurveyof
hazardous waste sites, toluene was detected atlevels of7.5 ppb
insurfacewaters, 21 ppbingroundwaters, and77ppbinsoil(10).
Toluenehasnotbeenobservedtobeamajorcontaminantinfood
ordrinkingwaterbutisknowntobeanindoorairpollutant. At-
mosphericcontminationoftoluenehasusuallybeenfoundtobe
at levels lower than 1 ppm (4). Toluene in the environment is
rapidly biodegraded and does nottend tobioaccumulate.
Absorption, Metabolism, and Toxicity
ofToluene
Duringprolongedinhalationexposurestotoluene, 75to80%
oftheinhaleddoseisinitiallyabsorbed,droppingtoapproximate-
ly50%absorption2to3hrlater(9). Between4and18%oftoluene
isexpiredunchangedthroughthelungs,and < 1% isexcretedun-
changed in the urine (9,11). Absorption ofingested toluene is
reportedtobeupto 100% (11).Tolueneismetabolizedprimarily
intheliverbypathwaysthatare similarinhumansandinother
mammalianspecies. Thehalf-lifeofeliminationoftoluenefrom
bloodinhumansisapproximately3.4hr, comparedto1 hrinrats
andmice(9).
The most commonly recognized toxic effect oftoluene is
neurotoxicity,witheffectsonliver,heart,andkidneyalsohaving
beenreported(11-13). Thetoxiceffectsoftoluenedonotappear
tobemediatedthroughabiologicallyactivemetabolite.
ReviewofReproductive/Develop-
mentalToxicity in Humans
Reviewsofstudiesofreproductiveanddevelopmentaltoxicity
inbothhumansandanimalsarebasedonliteratureidentifiedby
means of computerized searches of relevant data bases. The
designs and end points ofhuman epidemiological studies and
case reports identified inthis way are summarized in Table 1.
Epidemiological Studies
Increasedincidencesofurogenital, gastrointestinal, andcar-
diac anomalies among offspring of toluene-exposed mothers
wereindicatedbyacase-referantstudyofwomenwithoccupa-
tionalexposurestoorganicsolvents(tolueneandotheraromatic
hydrocarbons) (14). Althoughtheauthorsconsideredtoluenethe
mostlikelycausativeagent, concurrentexposurestoothersol-
vents limittheconfidence thatcan beplaced in this finding.
CaseReports
Deliberateinhalationbypregnantwomenofproducts suchas
paintreducer,paintthinner, andpaint, whicharereportedbythe
manufacturers(personalcommunication) tocontainasmuchas
99% toluene, is associated with a number of case reports of
adversereproductiveoutcome(15-17). Afiequentlyreportedef-
fectis intrauterinegrowthretardation, whichhasbeen record-
edinsevenoffspringofwomenwhoabusedtoluene-containing
productsduringpregnancy (16,17). Casesofprematuredelivery
(15,16), congenitalcranio-facial, limb, cardiac, renal, andcen-
tral nervous system (CNS) malformations (15-17), and a syn-
drome considered by the authors to be similar to fetal alcohol
syndrome(16)havealsobeenreported, aswereadverseeffects
on postnatal neurobehavioral development (15-17). The dura-
tionsandlevelsofexposurerequiredtoproducetheseeffectsare
notknown, althoughavailableinformationontolueneabusein
adultssuggeststhatexposurestypicallylastfor6to7hr/session
(2). Supportingtheconclusionthatmajorexposurestotoluene
wereoccurring, anumberofwomenhadrenaltubularacidosis,
ararecondition associated specifically withtoluene(16).
These cases provide evidence of an association between
prenatal exposures to toluene and developmental toxicity in
humans. This evidence is limited, however, by the potentially
confounding effects of other fetotoxic agents (e.g., tobacco
smoke, alcohol) towhichthesubjectsmayhavebeenexposed.
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Also of concern are exposures to other potentially fetotoxic
substances thatoccur asdeliberate oraccidental admixtures in
the toluene-containing products.
Thereareno reportsofreproductive toxicity inmales, withthe
exceptionofasinglecasereportsuggestingthatprolongedabuse
oftoluenemayproducetesticularatrophyandreducedsperma-
togenesis (3). A 28-year-old male who had been chronically
abusingtoluenefor 10years, andwhoapparently diedasaresult
ofexcessive sniffing, wasfoundtohavedegenerationofthesper-
matogoniaandSertolicellsandshowedevidenceoffaultyorsup-
pressed spermatogenesis. Evidence ofcerebral and cerebellar
degeneration and mild liverdisease was also reported.
Review of Reproductive/Develop-
mental Toxicity in Animals
Anumberofexperimental studiesinvestigating thereproduc-
tiveanddevelopmental toxicityoftoluenehavebeenconducted
usingrats, mice, andrabbits. Thesestudiesprovideconvincing
evidencethatexposuresofdamstotolueneduringgestationcause
fetotoxicity. Theevidenceforfemalereproductivetoxicity (i.e.,
adverse effects oftoluene on female reproductive function) is
limited, and there is no evidence in animals that toluene ex-
posures are associated with adverse reproductive effects in
males. Designs and end points ofthe animal studies are sum-
marized inTable 2.
Transplacental Toxicokinetics
While there are no quantitative data for the transplacental
transferoftolueneinhumans, thereisonecasereportoftoluene
beingdetectedintheserumofanewborninfant(16). Inmice, one
studydemonstratedthatapproximately 10% ofaninhaleddose
oftoluenewasrapidlydistributedtothefetuses. Tissuedistribu-
tionwithinthefetusappearedtovarywithtimeofadministration
during the course of gestation. Administration at day 11 of
Table2. Studiesofreproductive and/ordevelopmentaltoxicity oftoluene inanimal models.
Authors Type ofstudy Species (strain) Exposureparameters
Toxicokinetic studies
Ghantous and Danielsson, 1986 (18) Placental transferanddistribution Mouse (C57BL) 2000ppmby inhalationday 11, 14, or 17
gestation (10min) (dams) or 115 yg by
subcutaneous injection (4-day-old
pups)
Teratology/fetotoxicity studies
(inhalation)
International Research and Develop-
ment Corporation (forthe
American Petroleum Institute),
1985 (19)
Ungvary and Tatrai, 1985 (20)
Tatrai etal., 1980 (21)
Hudak and Ungvary, 1978 (22)
Courtney etal., 1986 (24)
Shigeta etal., 1981 (25)
Litton Bionetics, 1978 (26)
Reproductive anddevelopmental
toxicity
Teratology and fetotoxicity
Teratology and fetotoxicity
Teratology and fetotoxicity
Teratology and postnatal development
(lactic dehydrogenaseactivity)
Teratology and fetal development
Teratology
Rat (CR.CD)
Mouse (CFLP)
Rabbit (NZ)
Rat (CFY)
Mouse (CFLP)
Rat (CFY)
Mouse (CD-1)
Mouse (ICR)
Rat (CRL:COBS CD (SD) BR)
100, 500, or2000ppmby inhalation
daily from 80days before mating
through lactation (6hr/day) (dams all
concentrations, sires athighestcon-
centrationonly)
133, 266, or399 ppmby inhalation on
days6-15 gestation (3 x 4 hr/day)
(dams)
133 or266ppmby inhalationdays 7-20
gestation (24hr/day) (dams)
266ppmby inhalation, days 7-14 gesta-
tion (24hr/day) (dams)
133 or399 ppmby inhalation, days 6-13
gestation (24hr/day) (dams)
399 ppmby inhalation, days9-14 gesta-
tion(24 hr/day) or399 ppmby in-
halation, days 1-8gestation (24
hr/day) (dams) or266 ppmby inhala-
tion, days 1-21 gestation (8 hr/day)
(dams)
200or400ppmby inhalation, days
7-16gestation(7 hr/day) (dams)
100or 1000ppmby inhalation, days
1-17 gestation(6hr/day) (dams)
100 or400 ppmby inhalation, days 6-15
gestation (6 hr/day) (dams)
Teratology/fetotoxicity studies (gavage)
Nawrot and Staples, 1979 (23) Teratology and fetotoxicity Mouse (CD-1) 0.9, 1.5, or3.0mg/kg/day, days 6-15
gestation or3.0mg/kg/day, days 12-15
gestation
Postnatal neurobehavioral studies
Shigeta etal., 1986 (27)
Kostas and Hotchin, 1981 (28)
Postnatal cognitive function
Postnatal neurobehavioral
development
Rat (high avoidanceorWistar)
Mouse (Nya: NYLAR)
100ppmby inhalation, day 13 gestation
untilday 48 postnatal
16, 80, or400ppm indrinking water
throughoutgestation, lactation, and
nostweamins FwotTV%AMAARAAB
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gestationresultedinevendistributionamongtissues, whilelater
administrations(days 14or 17ofgestation)producedaccumula-
tion in fetal liver (18).
Fetal Development
Reductionoflatefetalbodyweightandretardationofskeletal
developmentwerethemostconsistentfetotoxiceffectsdemon-
stratedinanimals. Convincingevidenceforretardationofsomatic
development comes from a study in which rat dams of strain
CR.CD wereexposed in inhalationchambersto0, 100,500, or
2000ppmtoluene(>99.99%pure)for6hr/day(begining80days
priortomating,excludingday20ofgestation)andsacrificedon
day21 ofgestation(19). Themeanbodyweightsoffetusesfrom
damsexposedto2000ppmtolueneweresignificantlylowerthan
controls(Table 3). Therewasnoevidenceofmaternaltoxicityin
thesedams (Table 4). Thisstudyusedappropriatecontrolsand
adequate numbers ofanimals and was conducted according to
GoodLaboratoryPracticeprotocols. Theno-observed-adverse-
effect level (NOAEL) inthis study was500ppm; however, itis
possiblethatthetruethresholdforadverseeffectsdetectableina
study such as this may lie between 500 ppm and the high dose
(2000ppm) thatwasassociatedwithfetotoxicity.
Theassociationbetweentolueneexposureandfetotoxicity is
alsosupportedbyeffectsonfetalsomaticdevelopmentinseveral
otherstudies(20-24), whicharesummarizedinTable3. Effects
oftolueneexposureonlatefetalweightsandskeletalmaturation
werereportedinratsandmice; datainrabbitsareweak. Pbten-
tialmethodological issues limitthevalueofthesestudiesThese
issuesincludequestionableexposureparameters(e.g.,exposure
in inhalation chambers for 24 hr/day for several consecutive
days), incompletereportingofparametersofmaternaltoxicity,
useofindividualpupsratherthanlittersasthebasisforstatistical
analyses, andpurity ofthe testmaterial.
Inoneofthesestudies, fetusesofratdamsexposedto399ppm
toluenefor24hr/dayondays I to 8ofgestationhadlowerbody
weightsthananyothergroupincludingtwocontrolgroups(22).
Thepercentageofweight-retarded (i.e., < 3.3 gbody weight)
fetuses among these dams was also increased. Anappropriate
controlgroupforthisexperimentalgroupwasnotincludedinthis
study, however, anditisnotclearwhichcontrolgroupwasused
forstatisticalanalyses. Additionally, 5oftheoriginal 14damsin
thistreatmentgroupdiedpriortodelivery (Table 4), although
theremainingdams werereported to show nosignsoftoxicity.
Thefetotoxiceffectobservedmaybetimedependent: fetusesof
damsexposedtothe sameconcentrationoftoluenefor24hr/day
ondays9to 14insteadofdays 1 to8ofgestationwerenotreported
to show any indications of developmental retardation. The
mechanismbywhichsuchatime-dependenteffectmightoperate
isunclear, sinceearlyembryonicexposuresmightbeexpected
toproducemalformationsratherthandevelopmentalretardation.
Further studies arerequired to resolvethis issue.
Reductions infetalweights atterm werealsodemonstratedin
twostudies inwhichpregnantmicewereexposedbyinhalation
totolueneat 133ppmfor24hr/day ondays6to 13gestation(22)
or by exposure to 1.5 or 3.0 mL/kg via gavage ondays 6 to 15
gestation(23). Datafromthesestudies arepresentedinTable3.
[ThestudybyNawrotandStaples(23)hasbeenreportedinthe
literature only in abstract form, but additional data in Table 3
were supplied by one ofthe authors (R. E. Staples, personal
communication)]. AfurtherstudybyUngvaryandTatraidem-
onstratedanincreaseintheincidenceofweight-retardedfetuses
(i.e., < 0.9 g body weight) among dams exposed to 266 ppm
tolueneviainhalationchambers3periodsof4hroneachdaybe-
tweendays6to 15ofgestation(20). Thisindexofdevelopmen-
talretardation wasalsoincreasedinthefetusesofdamsexpos-
edto 133ppmtolueneintheotherstudywheremeanfetalweight
was reduced (22).
ThestudybyNawrotandStaplesdemonstrateddecreasedfetal
weightsamongdamsexposedto 1.5or3.0mLtoluene/kgbody
weight on days 6 to 15 of gestation, while no effect on fetal
weightswasobservedindamsexposedto3.0mL/kgondays 12
to 15ofgestation(23). Maternaltoxicitywasreportedtobeab-
sentinthesedams, althoughexposureto3.0mLtoluene/dayon
days 12 to 15 ofgestationinanothergroupofpregnantanimals
didresultindecreasedweightgainamongthosedams. Oneofthe
authorshasquestionedthereportedabsenceofmaternaltoxicity
inthis study (R. E. Staples, personalcommunication).
WiththepossibleexceptionsofsomegroupsintheNawrotand
Staplesstudy(23)andthegroupofratsexposedto399ppmtoluene
ondaysIto8ofgestationinthestudybyHudakandUngvary(22),
therewasnoevidenceforasignificantdegreeofmaternaltoxici-
tyinratsormiceinanyofthesestudies.Maternaltoxicityinrab-
bitsdidresultfromexposureto266ppmtoluenefor24hr/dayon
days7to20ofgestation(20).Indicesofpossiblematernaltoxicity
weregenerallypoorlyreportedinthesestudies,however,andthe
availabledataaresummarizedinTable 4.
Inadditiontodecreasedbodyweight,fetalskeletaldevelopment
wasalsoconsistently affected. TheInternational Researchand
Development Corporation (IRDC) study demonstrated a non-
significant increase in incidence ofskeletally-retarded fetuses
(SRF)fromratdamsexposedsubchronicallyto2000ppmtoluene
for6hr/day(19)(Table 3).Significantincreasesinincidencesof
SRFamongpregnantratswerereportedfromavarietyofexposure
scenarios(266ppmtoluenefor8hr/dayondays 1 to21 ofgesta-
tion(22)orfor24hr/dayondays7to14ofgestation(21)andto399
ppmtoluenefor24hr/dayondays 1 to8ofgestation(22).
In mice, a significant increase was also reported in the in-
cidenceofSRFresultingfromexposuresto266ppmtoluenefor
12hr/dayondays6to 15 ofgestation(20). Asignificantincrease
intheincidenceoffetuseswitha 13/13ribprofilefromdamsthat
hadbeenexposed to 400ppmtoluenefor7 hr/day ondays 7 to
16ofgestationwasalsoreported(24). Itisunclearwhetherthis
resultisadverse, sincethisprofileisconsiderednormal. Incon-
junction with a significant increase in the incidence offetuses
withenlargedrenalpelvesinthe200ppmtreatmentgroup, the
authorsspeculatedthatthisfindingsuggesteddesynchronization
ofgrowth andmaturation.
Teratology
There is little evidence that exposure to toluene produces
teratogenic effects. Asignificantincreaseinincidenceoffetuses
withextra 14thribs indamsexposedto 1000ppmtoluenefor6
hr/dayondays 1 to 17ofgestationwasreportedbyShigettaetal.
(25). A significant increase in the incidence ofcleft palate in
mouse fetuses from dams receiving 3 doses/day of 1.0 mL
toluene/kg viagavagewasalsoreportedby NawrotandStaples
(23). A study by Litton Bionetics, Inc. for the American Pe-
troleum Institute (26), using GLP procedures and standard
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alble 3. Summary ofweight andskeletal retardation in fetusesofdamsexposed totoluene.
Weight-retarded Skeletal-retarded
Reference Species Strain Fetal exposure No. ofdams Weight, ga fetuses, % fetuses, %
(19) Rats CR.CD Control 18 3.6 ± 0.25 NRb 14.3
2000ppm (6hr/day, 80days
before
mating through lactation)
18 3.3 ± 0.22
(p < 0.01)
NR 24.4
Control
266ppm (24 hr/day, 7-14dg)c
Control (24 hr/day, 9-14dg)
399 ppm (24hr/day, 9-14dg)
Control (8 hr/day, 1-21 dg)
266 ppm (8 hr/day, 1-21 dg)
399 ppm (24hr/day, 1-8dg)
Crl:COBS Control
CD (SD) BR 100 ppm (6hr/day, 6-15 dg)
400ppm (6hr/day, 6-15 dg)
Control
133 ppm (3 x 4 hr/day, 6-15 dg)
266 ppm (3 x 4 hr/day, 6-15 dg)
399 ppm (24 hr/day, 6-15 dg)
21 3.94 ± 0.02 2.8
18 3.91 ± 0.02 3.3
13
31
(p < 0.05)
26 3.76 ± 0.02 6.9 6.5
19 3.75 ± 0.03 17.3 6
10 3.81 ± 0.03 7.2 0
10 3.61 ± 0.03 16.0 25
(p < 0.05)
9 3.31 ± 0.08 46.0 17
(p < 0.05) (p < 0.05) (p <0.05)
27 3.6
27 3.5
27 3.8
115 NR
15 NR
15 NR
15 -
NR
NR
NR
7
10
29
(p < 0.05)
NR
No effect
No effect
5
8
12
(p < 0.05)
- (All dams died)
(22)
(R. E. Staples,
personal com-
munication; 23)
(24)
(20)
Mice CFLP
Mice
Mice
Rabbits
CD-1
CD-1
NZ
aMeans ± SD.
bNR, data not reported.
cdg, days ofgestation.
Control
133 ppm (24 hr/day, 6-13 dg)
399 ppm (24 hr/day, 6-13 dg)
Control
0.9 mL/kg (3 x 0.3 mL, 6-15 dg)
1.5 mL/kg (3 x 0.5 mL, 6-15 dg)
3.0 mL/kg (3 x 1.0 mL, 6-15 dg)
3.0mL/kg (3 x 1.0 mL,
12-15 dg)
Control
200 ppm (7 hr/day, 7-16 dg)
400 ppm (7 hr/day, 7-16 dg)
Control (24 hr/day, 7-20dg)
133 ppm (24 hr/day, 7-20dg)
266 ppm (24 hr/day, 7-20dg)
14 1.07 ± 0.01
11 0.96 ± 0.01
(p < 0.01)
15 -
95 0.93
24 0.92
26 0.87
(Significantly
lower)
25 0.79
(Significantly
lower)
NR Noeffect
15 1.11
16 1.11
16 1.07
6.5
27.6
(p < 0.05)
NR
NR
NR
NR
NR
NR
NR
NR
60 33.0 ± 1.06 (M) NR
32.7 ± 0.86 (F) NR
10 33.2 ± 1.88(M) NR
31.9±1.75(F) NR
8 All fetuses died
5.0
1.9
- (All dams died)
NR
NR
NR
NR
NR
NR
NR
NR
40
54
protocols, found noevidenceofteratogenicity following mater-
nal exposures to 100 or 400 ppm toluene by inhalation for 6
hr/day ondays6 to 15 gestation.
Postnatal Maturation
Adverse effects onpostnatal maturation are associated with
gestational exposures to toluene atcertain levels ofexposure.
Data onpostnataldevelopmentfromthestudybyIRDC(19) are
summarized inTable 5. Prolonged maternal exposure to2000
ppmtoluenefor6hr/daybeforeandduringgestationclearlyhad
amarkedeffectonpostnatalweightgainofratpups upto wean-
ing. Incontrast, maternal exposuresto400 ppmfor6hr/day on
days7to 16ofgestationinthestudybyCourtney etal. (24)had
nosignificanteffect on pupbodyweights, althoughthetoluene-
treated pups were somewhat heavier than controls (Table 5).
There is also limited evidence for retardation of postnatal
physicaldevelopment asassessedby appearanceofdevelopmen-
tallandmarkssuch ashaireruptionand eyeopening(27). Post-
natalneurobehavioral andcognitivedevelopmenthasalsobeen
shown to be affected by prenatal and postnatal exposures to
toluene in rats (27) and inmice-(Z8).
(21) Rats
(22)
CFY
CFY Rats
(26) Rats
(20) Mice CFLP
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Abble4. Indicesofmaternaltoxicity inrats, mice, andrabbits.
Exposure group, ppm
Control
100
500
2000
0
2000
Control
133
266
399
Control
133
266
Control
266
Control'
399b
Controlc
266c
399d
Control
133
399
Control
0.9 mL/kg'
1.5 mL/kg'
3.0mL/kgW
3.0mL/kg'
Control
Maternal mortality, %
0
0
0
0
0
0
0
0
0
1t0
0
0
25
0
0
0
9.5
0
0
35.7
0
0
100
NR
NR
NR
NR
NR
0
0
0
Maternal weightgain
throughgestation, %
45.1
44.3
42.5
43.9
41.2
42.6
NR
NR
NR
NR
12.7
9.0
5.0*
68.8
65.8
52.4
41.8
46.6
44.1
44.0
NR
NR
NR
NR
NR
NR
NR9
12.7h
11.7h
10.6h
Maternal liverweight,
relative %
4.5
NRa
NR
4.9
NR
NR
NR
NR
NR
NR
3.0
3.0
3.6*
4.25
4.37*
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
7.69
7.23'
6.93i
aNR, data not reported.
'Exposed 24hr/day on days 9-14 ofgestation.
CEposed 8 hr/day on days 1-21 ofgestation.
dExposed 24hr/day ondays 1-8 ofgestation.
'Dose administered by gavage ondays 6-15 ofgestation.
fDose administered by gavage on days 12-15 ofgestation.
gReported tobe significantly lower thancontrol value, but magnitude ofeffect orprobability value not reported and no parallel control group included in study.
'Calculated on the basis ofthe reported increase in body weight (grams) and the mean initial body weight ofthe dams.
Reported tobe significantly lower than control value.
*p < 0.05.
Fetal andPupViability
Exposures to 266 ppm toluene for 24 hr/day on days 7 to
20 of gestation was associated with complete reproductive
failure in rabbits (20). Of eight pregnant does, two com-
pletely resorbed their litters, four aborted their litters, and
two died. Only one doe aborted in a group of ten animals
exposed to 133 ppm toluene for the same period, and one
of the concurrent control group of sixty pregnant does re-
sorbed her entire litter.
Significant increases in embryonic lethality were reported
to have occurred at all dose levels (0.9, 1.5, or 3.0 mg/kg/
day) in the study reported in abstract by Nawrot and Staples
(23). No data were presented in support of this conclusion.
These results could be considered either as develop-
mental effects or as female reproductive effects. No other
effects on female reproduction werereported in these studies.
Discussion
Itisclearfromtheresultsofstudiesinanimalsthattolueneis
associatedwithdevelopmentaltoxicity. Subchronic exposure to
toluene via inhalation for 6 hr/day atdose levels producing no
significant maternal toxicity in a well-controlled and well-
conducted study caused retardation ofboth fetal and postnatal
development(19). Resultsfromthisstudy aresupportedby con-
sistenteffectsfromother, less robuststudies (20-23). Associa-
tionsbetweentoluene exposuresandadverseeffects onpostnatal
developmenthave also been suggestedby a numberofstudies,
althoughtheevidence is limited atpresent (19,27,28). Someof
theadverse outcomes inoffspringascribedtotoluenesniffingby
pregnant women, such as intrauterine growth retardation and
delayedpostnatal development, are similar to theprenatal and
postnatal developmental retardation associated with prenatal
toluene exposures inexperimental animal studies. Othereffects
that occurinhumans, such asfacialandvisceralmalformations,
havenotbeenreportedinnonhumanspecies. Itisclear, however,
thatexposuretotoluene may present ahazardto thedeveloping
organism.
TheNOAELfrom the LRDC study in ratsis500 ppm(19). Ex-
posure of rats to 500 ppm of toluene in air for 6 hr/day is
esfimatedtoresultin atotaldailyintakeof112.5mg/kg/day(lable
6). Adverse effects (low fetalweights atterm) werereported to
Reference
(19)
Species
Rat
(20) Mouse
Rabbit
(21)
(22)
Rat
Rat
Mouse
(23) Mouse
(24) Mouse
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Table5. Pstnatal pup mean body weights(grms) for rats (19) and mice (24).
Tolueneconcentration, ppm
Postnatal day (sex) 0 (M+F)a 100 (M+F) 500 (M+F) 2000 (M+F) 2000 (M) 2000 (F)
Rats
I (M) 6.5 6.4 6.4 5.7* 6.4 5.9*
(F) 6.0 5.9 6.2 5.3' 6.1 5.5*
4BRb (M) 9.0 8.9 8.9 7.8* 9.3 8.1
(F) 8.7 8.4 8.7 7.2T 8.9 7.6t
4 AR (M) 9.0 8.8 8.8 7.8t 9.3 8.1*
(F) 8.6 8.4 8.7 7.2' 8.9 7.6*
14 (M) 22.8 23.9 22.0 19.6* 23.9 19.7'
(F) 22.0 22.8 21.3 18& 22.9 18.2'
21 (M) 36.1 38.9 35.8 31.1* 38.9 30.8k
(F) 34.8 37.4 35.0 29.5* 37.3 28.8'
Mice Toluene concentration, ppm
0 400
1 1.36 1.52
21 6.53 7.15
'Parental exposure, male (M) or female (F), parental groups that are not indicated were notexposed to toluene.
bBR, before reduction in litter size toeightpups/litter; AR, after reduction in litter size.
*p < 0.05.
tp < 0.01.
Table6. Estimated total daily intakesforhumans, mice, andratsexposed totoluene.
Duration perday, Estimated absorption, Body weight, Total daily intake,
Species Exposure hr % kg mg/kg/day
Human' 100ppm (inhalation) (375 mg/m3) 8 50 55 34
500ppm(inhalation)" (1875 mg/m3) 6 50 55 127.5
Mousec 200ppm (inhalation) (750 mg/m3) 7 50 0.03 157.5d
133 ppm (inhalation) (500 mg/m3) 12 50 0.03 180
400ppm (inhalation) (1500 mg/m3) 6 50 0.03 270
400 ppm (inhalation) (1500mg/m3) 7 50 0.03 315d
133 ppm (inhalation) (500 mg/m3) 24 50 0.03 360d
266 ppm (inhalation) (1000 mg/m3) 12 50 0.03 360d
399 ppm (inhalation) (1500 mg/m3) 24 50 0.03 1080d
0.9 mL/kg (gavage)e 100 0.03 780d
1.5 mL/kg (gavage) 100 0.03 1300d
3.0mL/kg (gavage) 100 0.03 2600"
Ratf 100ppm (inhalation) (375 mg/m3) 6 50 0.3 22.5
266ppm (inhalation) (1000mg/m3) 8 50 0.3 80d
500 ppm (inhalation) (1875 mg/m3) 6 50 0.3 112.5
266 ppm (inhalation) (1000mg/m3) 24 50 0.3 240d
399 ppm (inhalation) (1500mg/m3) 24 50 0.3 360d
2000 ppm (inhalation) (7500mg/m3) 6 50 0.3 450d
aHuman respiratory volumeestimated to be 1250 L/hr.
bExposure level reported to cause euphoria in humans.
cMouse respiratory volume estimated to be 1.8 L/hr.
dTotal daily intakes reported to cause toxicity in the fetuses, dams, orboth.
'One milliliter oftoluene = 866.9 mg.
fRat respiratory volume estimated to be 6 L/hr.
haveoccurredinratsofadifferentstrainatantotaldailyintakeof
80mg/kg/day (22). Thequestionablequality ofthis andother
studiesthatprovideapparentNOAELsthatarelowerthan112.5
mg/kg/daymakeitinappropriatetousesuchdataincalculatingan
exposurelevelthatwouldbeconsideredacceptableforhumans.
If112.5 mg/kg/day wastreatedasano-observed-effectlevel
(NOEL) forthepurposesofCalifornia'sProposition65, aman-
datory safetyfactorof1000wouldbeapplied, resultingin anac-
ceptable daily intake level for humans of0.1125 mg/kg/day.
Using the procedures developed by the U.S. Environmental
Protection Agency (EPA), an uncertainty factor of 100 (a
10-foldfactorforintraspeciesvariability x a 10-foldfactorfor
interspecies variability) could be applied to this NOAEL,
resulting in a reference dose (RfD) of 1.125 mg/kg/day in
humans (29).
Table 6 compares the estimated daily absorbed doses for a
55-kg human female at the permissible exposure level of 100
ppmandfromtheminimumexposureexpectedtooccurduring
inhalationabuseoftoluene, withestimatesofabsorbeddosesfor
miceandratsattheexposureregimensemployedinthestudies
reviewed here. The human exposure level of 34 mg/kg/day
estimatedfromtheU.S. OSHAandtheCaliforniaOSHAper-
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missible exposure levels of 100 ppm is within an order of
magnitudeoftheexposurelevelsthatcauseadverseeffectsinrats
andmice. Itisalsoapparentthatabuseoftolueneforitseuphoric
effects will resultinexposure levelsthatmatchorexceedthose
producing adverse effects inthese animal models.
Theauthors thank Laurie Monserrat for hercontributions tothis work.
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